<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0005110'>Atrial fibrillation</z:hpo> is the most common sustained <z:hpo ids='HP_0011675'>arrhythmia</z:hpo> encountered in clinical practice </plain></SENT>
<SENT sid="1" pm="."><plain>Its prevalence is rising due to an increasing elderly population and the improvement in management of life-threatening diseases such as <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo> and <z:hpo ids='HP_0001635'>heart failure</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Over the past few years effective non-pharmacological treatments, new antiarrhythmics drugs, and <z:chebi fb="2" ids="50249">anticoagulants</z:chebi> have been introduced </plain></SENT>
<SENT sid="3" pm="."><plain>Regardless of rate-control or rhythm control strategy, adequate <z:hpo ids='HP_0001297'>stroke</z:hpo> prevention still remains a cornerstone in the treatment of this <z:hpo ids='HP_0011675'>arrhythmia</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>This review aims to illustrate the main practical issues in the management of <z:hpo ids='HP_0005110'>atrial fibrillation</z:hpo>, focusing on patients with recent-<z:hpo ids='HP_0003674'>onset</z:hpo> and hemodynamically stable <z:hpo ids='HP_0005110'>atrial fibrillation</z:hpo> </plain></SENT>
</text></document>